Friday, January 30, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

North Korea Reveals New Carbon-Fiber ICBM Engine, Signaling Extended Range and Multiple Warhead Capability

North Korea claims successful development of a new missile engine, hinting at an ICBM launch soon to showcase advanced capabilities.

Samsung to Retire Over 50 Million Shares in KRW 3.5 Trillion Buyback

Samsung Electronics plans to retire over 50 M shares, investing KRW 3.5 trillion to enhance shareholder value and stabilize stock prices.

Tag: entrepreneurship

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.